Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): a randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancer

Reimer, Toralf; Stachs, Angrit; Veselinovic, Kristina; Polata, Silke; Müller, Thomas; Kühn, Thorsten; Heil, Jörg; Ataseven, Beyhan; Reitsamer, Roland; Hildebrandt, Guido; Knauer, Michael; Golatta, Michael; Stefek, Andrea; Zahm, Dirk-Michael; Thill, Marc; Nekljudova, Valentina; Krug, David; Loibl, Sibylle; Gerber, Bernd

doi:10.1016/j.eclinm.2022.101756

Public

Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): a randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancer

Published in EClinicalMedicine • Nov 25, 2022

Authors:

Toralf Reimer

Angrit Stachs

Kristina Veselinovic

Abstract

Background: In clinically node-negative breast cancer patients, the INSEMA trial (NCT02466737) assessed the non-inferiority of avoiding sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND). Here we present patient-reported outcomes (PROs) as a secondary endpoint. Methods: PROs ...

Subject

Medicine

Breast cancer

Breast surgery

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!